RNA 간섭 기술 시장 : 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

RNA Interference Technology Market size was valued at USD 1,545.62 Million in 2023, expanding at a CAGR of 16.5% from 2024 to 2032.

The RNA interference (RNAi) technology market involves using small RNA molecules to silence gene expression, with applications in gene therapy, drug discovery, and functional genomics. Increasing demand for precise therapies in personalized medicine, and advancements in drug delivery systems enabling efficient RNAi-based treatments are driving the demand for the market. However, challenges such as off-target effects, and delivery complexities impede market growth. Opportunities exist in applying RNAi to neurodegenerative diseases, forming partnerships for innovative therapies and delivery methods, and entering untapped markets in developing regions with rising healthcare investment and research activity, promising prospects for RNAi technology adoption.

RNA Interference Technology Market- Market Dynamics

RNA Interference Technology's Role in Advancing Precision Medicine

RNA interference (RNAi) technology is pivotal in advancing precision medicine by offering personalized treatment options. For instance, researchers at the National Institutes of Health (NIH) have utilized RNAi to target specific genes implicated in cancer, demonstrating promising results in tumor suppression and personalized therapy approaches. Additionally, pharmaceutical companies like Alnylam Pharmaceuticals have developed RNAi-based therapeutics for rare genetic disorders, exemplifying the transformative potential of RNAi in addressing individual patient needs. This technology enables precise gene silencing tailored to patient-specific genetic profiles, facilitating the development of targeted therapies with enhanced efficacy and reduced side effects, thereby revolutionizing the landscape of personalized medicine.

RNA Interference Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2024-2032)

Based on Type segmentation, siRNA was predicted to show maximum market share in the year 2023

Based on application segmentation, therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

RNA Interference Technology Market- Segmentation Analysis:

The Global RNA Interference Technology Market is segmented based on Type, Application, End-Users, and Region.

The market is divided into three categories based on Type: dsRNA, siRNA, and miRNA. Short interfering RNA (siRNA) holds the highest preference due to its specificity and effectiveness in gene silencing, followed by microRNA (miRNA), known for its regulatory role in gene expression. Double-stranded RNA (dsRNA) is less favored due to off-target effects and innate immune responses.

The market is divided into three categories based on application: Drug Discovery and Development, Therapeutics, and Agricultural Crop Modifications. Therapeutics ranks highest, driven by increasing demand for RNAi-based treatments in precision medicine and personalized therapies. Drug discovery and development follow closely, leveraging RNAi technology for target validation and drug screening. Agricultural crop modifications and other applications exhibit lower preference due to regulatory challenges and market complexity.

RNA Interference Technology Market- Geographical Insights

North America, particularly the United States, leads the market with robust research and development activities in the biotechnology and pharmaceutical sectors, supported by key players like Alnylam Pharmaceuticals and Arrowhead Pharmaceuticals. In Europe, countries such as Germany, the UK, and Switzerland drive adoption through strong biomedical research and clinical applications, bolstered by academic-industry collaborations. The Asia Pacific region shows rapid growth, driven by increasing healthcare expenditure, biotechnology research investments, and governmental support for genomic medicine in countries like China, Japan, and India. Latin America presents opportunities fueled by the focus on precision medicine and genetic therapies, with improving healthcare infrastructure and regulatory developments aiding market expansion. The Middle East and Africa also see growth, supported by healthcare infrastructure investments and rising awareness about personalized medicine, with collaborations enhancing technology transfer and market development in the region.

RNA Interference Technology Market- Competitive Landscape:

Several key players such as Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Quark Pharmaceuticals, and Silence Therapeutics, all drive innovation and product development in RNAi-based therapeutics. Alnylam Pharmaceuticals stands out for its focus on rare genetic diseases, while Arrowhead Pharmaceuticals specializes in RNAi-based drugs for liver diseases and cancer. Notable instances of collaboration include Alnylam Pharmaceuticals' partnership with Regeneron Pharmaceuticals to develop RNAi-based treatments for ocular and CNS diseases, leveraging Alnylam's expertise in RNAi therapeutics and Regeneron's capabilities in antibody technologies. Dicerna Pharmaceuticals leverages its proprietary RNAi technology platform for various disease pathways, and Quark Pharmaceuticals focuses on ocular diseases and kidney injuries. Silence Therapeutics develops RNAi therapies for cardiovascular diseases, cancer, and rare genetic disorders using advanced delivery systems. These companies compete on technological advancements, therapeutic pipelines, and strategic collaborations with academic and pharmaceutical partners, reflecting a dynamic market landscape with ongoing research and clinical trials to demonstrate the efficacy and safety of RNAi-based therapies.

Recent Developments:

In April 2024, Medison Pharma and Alnylam Pharmaceuticals, Inc. announced a further expansion of their existing partnership in Central & Eastern Europe and Israel, to commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia.

In June 2023, Canada's Pest Management Research Agency approved a field study for RNAi biopesticide delivery technology, which is an eco-friendly way to protect crops from insects.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alnylam Pharmaceuticals, Inc.

Arbutus Biopharma Corporation

Arrowhead Pharmaceuticals, Inc.

Benitec Biopharma Limited

DicereGen, Inc.

Dicerna Pharmaceuticals, Inc.

Gradalis, Inc.

Ionis Pharmaceuticals, Inc.

miRagen Therapeutics, Inc.

Quark Pharmaceuticals, Inc.

Regulus Therapeutics Inc.

RXi Pharmaceuticals Corporation

Silence Therapeutics plc

Sirnaomics, Inc.

Sylentis S.A.U. (PharmaMar Group)

Tacere Therapeutics, Inc.

Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

• dsRNA
• siRNA
• miRNA

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Drug Discovery and Development
• Therapeutics
• Agricultural Crop Modifications
• Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Academia
• Research Centers
• Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.RNA Interference Technology Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.RNA Interference Technology Market Snippet by Type
  • 2.1.2.RNA Interference Technology Market Snippet by Application
  • 2.1.3.RNA Interference Technology Market Snippet by End-Users
  • 2.1.4.RNA Interference Technology Market Snippet by Country
  • 2.1.5.RNA Interference Technology Market Snippet by Region
• 2.2.Competitive Insights

3.RNA Interference Technology Key Market Trends

• 3.1.RNA Interference Technology Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.RNA Interference Technology Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.RNA Interference Technology Market Opportunities
• 3.4.RNA Interference Technology Market Future Trends

4.RNA Interference Technology Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.RNA Interference Technology Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.RNA Interference Technology Market Landscape

• 6.1.RNA Interference Technology Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.RNA Interference Technology Market - By Type

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
  • 7.1.2.dsRNA
  • 7.1.3.siRNA
  • 7.1.4.miRNA

8.RNA Interference Technology Market - By Application

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2.Drug Discovery and Development
  • 8.1.3.Therapeutics
  • 8.1.4.Agricultural Crop Modifications
  • 8.1.5.Others

9.RNA Interference Technology Market - By End-Users

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By End-Users, 2023 & 2032 (%)
  • 9.1.2.Pharmaceutical Companies
  • 9.1.3.Biotechnology Companies
  • 9.1.4.Contract Research Organizations
  • 9.1.5.Academia
  • 9.1.6.Research Centers
  • 9.1.7.Others

10.RNA Interference Technology Market- By Geography

• 10.1.Introduction
  • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2.North America
  • 10.2.1.Overview
  • 10.2.2.RNA Interference Technology Key Manufacturers in North America
  • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6.North America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.2.7.U.S.
    • 10.2.7.1.Overview
    • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5.U.S. Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.2.8.Canada
    • 10.2.8.1.Overview
    • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5.Canada Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
• 10.3.Europe
  • 10.3.1.Overview
  • 10.3.2.RNA Interference Technology Key Manufacturers in Europe
  • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6.Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.7.Germany
    • 10.3.7.1.Overview
    • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5.Germany Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.8.Italy
    • 10.3.8.1.Overview
    • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5.Italy Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.9.United Kingdom
    • 10.3.9.1.Overview
    • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.10.France
    • 10.3.10.1.Overview
    • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5.France Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.11.Russia
    • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.4.Russia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.12.Netherlands
    • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.4.Netherlands Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.13.Sweden
    • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.4.Sweden Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.14.Poland
    • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.4.Poland Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.15.Rest of Europe
    • 10.3.15.1.Overview
    • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
• 10.4.Asia Pacific (APAC)
  • 10.4.1.Overview
  • 10.4.2.RNA Interference Technology Key Manufacturers in Asia Pacific
  • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6.Asia Pacific Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.7.India
    • 10.4.7.1.Overview
    • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5.India Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.8.China
    • 10.4.8.1.Overview
    • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5.China Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.9.Japan
    • 10.4.9.1.Overview
    • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5.Japan Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.10.South Korea
    • 10.4.10.1.Overview
    • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5.South Korea Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.11.Australia
    • 10.4.11.1.Overview
    • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5.Australia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.12.Thailand
    • 10.4.12.1.Overview
    • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5.Thailand Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.13.Indonesia
    • 10.4.13.1.Overview
    • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5.Indonesia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.14.Philippines
    • 10.4.14.1.Overview
    • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5.Philippines Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.15.Rest of APAC
    • 10.4.15.1.Overview
    • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
• 10.5.Latin America
  • 10.5.1.Overview
  • 10.5.2.RNA Interference Technology Key Manufacturers in Latin America
  • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6.Latin America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.5.7.Brazil
    • 10.5.7.1.Overview
    • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5.Brazil Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.5.8.Mexico
    • 10.5.8.1.Overview
    • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5.Mexico Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.5.9.Argentina
    • 10.5.9.1.Overview
    • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5.Argentina Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.5.10.Colombia
    • 10.5.10.1.Overview
    • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5.Colombia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.5.11.Rest of LATAM
    • 10.5.11.1.Overview
    • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
• 10.6.Middle East and Africa
  • 10.6.1.Overview
  • 10.6.2.RNA Interference Technology Key Manufacturers in Middle East and Africa
  • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.7.Saudi Arabia
    • 10.6.7.1.Overview
    • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.8.United Arab Emirates
    • 10.6.8.1.Overview
    • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.9.Israel
    • 10.6.9.1.Overview
    • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5.Israel Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.10.Turkey
    • 10.6.10.1.Overview
    • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5.Turkey Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.11.Algeria
    • 10.6.11.1.Overview
    • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5.Algeria Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.12.Egypt
    • 10.6.12.1.Overview
    • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5.Egypt Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.13.Rest of MEA
    • 10.6.13.1.Overview
    • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- RNA Interference Technology Industry

• 11.1.Competitive Dashboard
• 11.2.Company Profiles
  • 11.2.1.Alnylam Pharmaceuticals, Inc.
  • 11.2.2.Arbutus Biopharma Corporation
  • 11.2.3.Arrowhead Pharmaceuticals, Inc.
  • 11.2.4.Benitec Biopharma Limited
  • 11.2.5.DicereGen, Inc.
  • 11.2.6.Dicerna Pharmaceuticals, Inc.
  • 11.2.7.Gradalis, Inc.
  • 11.2.8.Ionis Pharmaceuticals, Inc.
  • 11.2.9.miRagen Therapeutics, Inc.
  • 11.2.10.Quark Pharmaceuticals, Inc.
  • 11.2.11.Regulus Therapeutics Inc.
  • 11.2.12.RXi Pharmaceuticals Corporation
  • 11.2.13.Silence Therapeutics plc
  • 11.2.14.Sirnaomics, Inc.
  • 11.2.15.Sylentis S.A.U. (PharmaMar Group)
  • 11.2.16.Tacere Therapeutics, Inc.
  • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

• 13.1.Research Methodology
• 13.2.References
• 13.3.Abbreviations
• 13.4.Disclaimer
• 13.5.Contact Us